Loading clinical trials...

A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01949324

A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

This study is a phase 2, randomized, multi-center, single-masked study to evaluate the efficacy and safety of the NT-501 implants in participants with Mactel.

Lead sponsor: Neurotech Pharmaceuticals•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 3

A Study to Determine the Safety and Efficacy of NT-501 With MHFM

NCT06397131 · Macular Telangiectasia Type 2

Not Yet RecruitingPhase 3

Study of Serine Supplementation to Protect Vision in MacTel

NCT07342439 · Macular Telangiectasia Type 2 (MacTel)

Not Yet RecruitingPhase 4

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

NCT06971939 · Macular Telangiectasia Type 2 (MacTel)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment67

Start dateApr 2014

Last updatedSep 12, 2018

Condition

Macular Telangiectasia Type 2

Locations shown

Jules Stein Eye Institute

Los Angeles, California

Bascom Palmer

Miami, Florida

Emory University

Atlanta, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions